Nov 16, 2022 9:25am EST 22nd Century Group’s GVB Biopharma Opens New Central Distribution Facility in The Netherlands
Nov 15, 2022 9:25am EST 22nd Century Group (Nasdaq: XXII) GVB Biopharma to Exhibit at MJBizCon in Las Vegas
Nov 14, 2022 8:19am EST 22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences
Nov 08, 2022 6:00am EST 22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022
Nov 07, 2022 9:43am EST New Study Again Shows 22nd Century’s Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking Cessation
Oct 27, 2022 9:15am EDT 22nd Century Group (Nasdaq: XXII) to Announce Third Quarter 2022 Results on November 8, 2022
Oct 26, 2022 9:25am EDT 22nd Century Group (Nasdaq: XXII) to Expand VLN® Sales in Three Additional States: Arizona, Utah and New Mexico
Oct 18, 2022 9:20am EDT 22nd Century Group (Nasdaq: XXII) to Present at LD Micro Conference on October 26
Oct 06, 2022 4:05pm EDT 22nd Century Group (Nasdaq: XXII) to Participate in the Dawson James Small Cap Growth Conference on October 12
